Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas- Figure out How to Alter Your Volvo XC40 for Further developed Solace
- Gauging the Upsides and downsides of Visas: A Complete Aide
- Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
- A definitive Manual for the 5 Off-road Bicycles Available
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight
- Step by step instructions to Involve Compact disc Rates for Magnanimous Giving
